Literature DB >> 9056547

Nonsense mutation in exon 3 of the proteolipid protein gene (PLP) in a family with an unusual form of Pelizaeus-Merzbacher disease.

M E Hodes1, C A Blank, V M Pratt, J Morales, J Napier, S R Dlouhy.   

Abstract

We report a G-->A transition at nucleotide 431 of the proteolipid protein gene (PLP) results in a nonsense codon in a family with an unusual form of Pelizaeus-Merzbacher disease (PMD). The mutation, which creates a second AluI restriction site, results in a nonsense mutation in PLP. The clinical picture resembles somewhat that of X-linked spastic paraplegia (SPG). It differs from this and both the classical and connatal forms of PMD in that it is relatively mild in form, onset is delayed beyond age 2 years, nystagmus is absent, tremors are prominent, mental retardation is not severe, some patients show dementia or personality disorders, the disease is progressive rather than static in some, and several females show signs of disease. The nonsense mutation, which is in exon 3B, should block the synthesis of normal PLP but spare DM20, the isoform whose persistence has been associated with mild forms of PLP-associated disease in both humans and mice.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9056547

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  8 in total

1.  Genetic Variations of Ultraconserved Elements in the Human Genome.

Authors:  Anamarija Habic; John S Mattick; George Adrian Calin; Rok Krese; Janez Konc; Tanja Kunej
Journal:  OMICS       Date:  2019-11

Review 2.  PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2.

Authors:  Ken Inoue
Journal:  Neurogenetics       Date:  2004-12-31       Impact factor: 2.660

3.  Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy.

Authors:  Michael E Shy; Grace Hobson; Manisha Jain; Odile Boespflug-Tanguy; James Garbern; Karen Sperle; Wen Li; Alex Gow; Diana Rodriguez; Enrico Bertini; Pedro Mancias; Karen Krajewski; Richard Lewis; John Kamholz
Journal:  Ann Neurol       Date:  2003-03       Impact factor: 10.422

4.  Insertion of mutant proteolipid protein results in missorting of myelin proteins.

Authors:  Catherine Vaurs-Barriere; Kondi Wong; Thais D Weibel; Mones Abu-Asab; Michael D Weiss; Christine R Kaneski; Tong-Hui Mixon; Simona Bonavita; Isabelle Creveaux; John D Heiss; Maria Tsokos; Ehud Goldin; Richard H Quarles; Odile Boespflug-Tanguy; Raphael Schiffmann
Journal:  Ann Neurol       Date:  2003-12       Impact factor: 10.422

5.  Differences in endoplasmic-reticulum quality control determine the cellular response to disease-associated mutants of proteolipid protein.

Authors:  Peristera Roboti; Eileithyia Swanton; Stephen High
Journal:  J Cell Sci       Date:  2009-10-13       Impact factor: 5.285

Review 6.  Neurogenetics of Pelizaeus-Merzbacher disease.

Authors:  M Joana Osório; Steven A Goldman
Journal:  Handb Clin Neurol       Date:  2018

Review 7.  Axon-glial interaction in the CNS: what we have learned from mouse models of Pelizaeus-Merzbacher disease.

Authors:  Fredrik I Gruenenfelder; Gemma Thomson; Jacques Penderis; Julia M Edgar
Journal:  J Anat       Date:  2011-03-14       Impact factor: 2.610

8.  Altered PLP1 splicing causes hypomyelination of early myelinating structures.

Authors:  Sietske H Kevelam; Jennifer R Taube; Rosalina M L van Spaendonk; Enrico Bertini; Karen Sperle; Mark Tarnopolsky; Davide Tonduti; Enza Maria Valente; Lorena Travaglini; Erik A Sistermans; Geneviève Bernard; Coriene E Catsman-Berrevoets; Clara D M van Karnebeek; John R Østergaard; Richard L Friederich; Mahmoud Fawzi Elsaid; Jolanda H Schieving; Maja Tarailo-Graovac; Simona Orcesi; Marjan E Steenweg; Carola G M van Berkel; Quinten Waisfisz; Truus E M Abbink; Marjo S van der Knaap; Grace M Hobson; Nicole I Wolf
Journal:  Ann Clin Transl Neurol       Date:  2015-05-01       Impact factor: 4.511

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.